Get Your Personalized Supplement StackSupplement Stack Quiz

Benfopure Benfotiamine

Also known as: Benfotiamine, S-benzoylthiamine O-monophosphate, Vitamin B1 derivative

Overview

Benfotiamine is a synthetic derivative of thiamine (Vitamin B1) designed to enhance lipid solubility, significantly increasing its bioavailability compared to traditional thiamine. This compound is commonly used as a dietary supplement to prevent and treat health issues related to thiamine deficiency, including peripheral neuropathy associated with diabetes and alcoholism, as well as for cognitive support. Benfotiamine is known for absorption rates approximately five times higher than regular thiamine. Although research shows promising effects, extensive trials are needed for validation. It is primarily available in capsule and tablet forms, facilitating improved thiamine intake.

Benefits

Research indicates that benfotiamine effectively manages peripheral neuropathy in patients with diabetes and alcohol use disorder, leading to modest improvements in vibration perception thresholds. Some evidence suggests it may enhance thiamine status in diabetic nephropathy, though findings on urinary albumin excretion and injury markers are inconclusive. A Phase 2 pilot study indicated potential cognitive benefits for individuals with mild cognitive impairment or Alzheimer's disease, but primary outcomes were not statistically significant. The strongest evidence supports benfotiamine's utility for diabetes-related complications, particularly neuropathy, necessitating further validation through rigorous research.

How it works

Upon ingestion, benfotiamine is converted into thiamine, functioning as a key coenzyme in metabolic pathways like glucose metabolism and the pentose phosphate pathway. Its lipid-soluble nature improves absorption and bioavailability, which is crucial for energy production and neuroprotection. Additionally, benfotiamine exhibits anti-inflammatory and antioxidant properties that enhance glucose metabolism and support cardiovascular health.

Side effects

Benfotiamine is generally well-tolerated, with common side effects reported in less than 5% of users. Uncommon side effects such as dizziness and mild urticaria may occur in 1-5% of individuals, while serious side effects are rare. There are minimal known drug interactions, although caution is advised when combined with medications affecting glucose metabolism or neurological functions. While no specific contraindications exist, individuals allergic to thiamine or its derivatives should avoid its use. Pregnant or breastfeeding women are encouraged to consult healthcare providers, as safety data in these groups is lacking.

Dosage

The typical recommended dosage of benfotiamine ranges from 80 to 150 mg per day, although some clinical trials have administered up to 600 mg daily. Ongoing research is exploring dosages up to 1200 mg/day. An established minimum effective dose is not available, but higher doses have demonstrated promising results in studies. For optimal absorption, it is advised to take benfotiamine with meals due to its lipid-soluble nature. Available forms include capsules and tablets, which may have differing absorption capabilities.

FAQs

Is benfotiamine safe to use?

Benfotiamine is generally considered safe, with rare side effects such as dizziness and urticaria reported. Consult a healthcare provider for individual concerns.

How should I take benfotiamine?

It's recommended to take benfotiamine with meals for better absorption.

What can I expect from benfotiamine?

Users may notice improvements in thiamine levels and potential benefits for peripheral neuropathy and cognitive health, although these are not universally confirmed.

Is benfotiamine a cure for diabetes or cognitive decline?

No, benfotiamine is not a cure but may provide supportive benefits in managing complications related to these conditions.

Research Sources

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070141/ – This systematic review highlights the efficacy of benfotiamine in managing diabetic neuropathy, noting modest improvements in clinical outcomes and suggesting its potential benefits in enhancing thiamine status in related disorders.
https://pubmed.ncbi.nlm.nih.gov/28745328/ – This pilot study explored the effects of benfotiamine on cognitive decline in Alzheimer's patients, though the primary outcomes were not statistically significant, indicating the need for further research.